Oral administration of a nonimmunosuppressant FKBP-12 ligand speeds nerve regeneration

NeuroReport

Volumn 9, Issue 3, 1998, Pages 553-558

  Gold, Bruce G ^a   Zeleny Pooley, Michelle ^a   Chaturvedi, Pravin ^b   Wang, Min Sheng ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b VERTEX PHARMACEUTICALS   (United States)

Author keywords

Calcineurin; Cyclosporin A; FK506; FKBP 12; Immunophilin; Immunosuppressant; Nerve regeneration; Sciatic nerve

Indexed keywords

CALCINEURIN; CYCLOSPORIN A; FK 506 BINDING PROTEIN; IMMUNOPHILIN; LIGAND; TACROLIMUS;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; MALE; NERVE INJURY; NERVE REGENERATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

EID: 0032536515     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199802160-00031     Document Type: Article

References (25)

1. McQuarrie IG, Gratstein B and Gershorn MB. Brain Res 132, 443-453 (1977).
2. Forman DS and Berenberg RA. Brain Res 156, 213-225 (1978).
3. Jacob JM and McQuarrie IG. J Neurobiol 24, 356-367 (1993).
4. Fu SY and Gordon T. Mol Neurobiol 14, 67-116 (1997).
5. Gold BG, Storm Dickerson T and Austin DR. Restor Neurol Neurosci 6, 287-296 (1994).
6. Gold BG, Katoh K and Storm-Dickerson T. J Neurosci 15, 7505-7516 (1995).
7. Wang MS, Zeleny-Pooley M and Gold BG. J Pharmacol Exp Ther 282, 1084-1093 (1997).
8. Friedman J and Weissman I. Cell 66, 799-806 (1991).
9. Nelson PA, Akselband Y, Kawamura A et al. J Immunol 150, 2139-2147 (1993).
10. Liu J, Farmer JD, Lane WS et al. Cell 66, 807-815 (1991).
11. Liu J, Albers MW, Wandless TJ et al. Biochem 31, 3896-3901 (1992).
12. Wicderrecht G, Lam E, Hung S et al. Ann NY Acad Sci 696, 9-19 (1993).
13. Cardenas ME, Zhu D and Heitman I. Curr Opin Nephrol Hypertens 4, 472-477 (1995).
14. Harding MW, Galat A, Uehling DE and Schreiber SL. Nature 341, 758-760 (1989).
15. Siekierka JJ, Hung SHY, Poe M et al. Nature 341, 755-757 (1989).
16. Sigal NH and Dumont FJ. Aunu Rev Immunol 10, 519-560 (1992).
17. Wiederrecht G and Etzkorn F. Perspect Drug Design 2, 57-84 (1994).
18. Gold BG, Zeleny Pooley BS, Wang M-S et al. Exp Neurol 147, 269-278 (1997).
19. Steiner JP, Hamilton GS, Ross DT et al. Proc Natl Acad Sci USA 94, 2019-2024 (1997).
20. Steiner JP, Connolly MA, Valentine HL et al. Nature Med 3, 1-8 (1997).
21. Armistead DM, Badia MC, Deininger DD et al. Acta Crystallogr 51, 522-528 (1995).
22. Gold BG, Zeleny Pooley BS, Wang M-S et al. Soc Neurosci Abstr 23, 1131 (1997).
23. Walker JL, Resig P, Guamieri S et al. Neurol Neurosci 6, 189-193 (1994).
24. Rasminsky M. Physiology of conduction in demyelinated axons. In: Waxman SG, ed. Physiology and Pathobiology of Axons. New York: Raven Press, 1978: 361-376.
25. Gold BG. Mol Neurobiol 15, 285-306 (1997).